Bold Business Logo

Via and Mercedes Benz Sign Joint Venture

Daimler, the German-based manufacturer of Mercedes-Benz vehicles, recently invested in Via Transportation, Inc. and also signed a joint venture agreement with the company. Via is a ride-sharing transportation network in direct competition with Uber. They are strictly into multiple passengers, with the bold idea of picking up various passengers along a common route. It is cost effective and efficient.

So far, it raised a total of $387 million in five rounds. Currently, the company has a valuation of around $750 million.

Via is licensing their technology to transit systems, enabling them to compete against ride-sharing apps. Uber has a similar service called uberPOOL. In these carpooling apps, passengers use the app to signify their pickup point for a particular destination.

One problem for ride sharing utilities is that they sometimes divert the route far afield to pick up and drop off a second passenger. The result is longer travel times as the ride meanders around picking up people here and there on its route. The new traffic aids and navigation apps should allow for optimized ride shares, as more people use them allowing for greater density in given areas, and the technology develops to make routes more efficient. The downside of sharing a ride is longer travel time, the upside is cheaper fares.

uberPOOL works by asking passengers to go to an assigned pickup location – a common waiting area where the passengers and vans meet up. This reduces the passenger pickup time as the van does not have to stop multiple times or drive farther just to pick up individual passengers.

Mercedes Benz Investment

Mercedes-Benz invested $50 million in funding for Via, with the latest round raising $250 million for the startup. So far, it raised a total of $387 million in five rounds. Currently, the company has a valuation of around $750 million. Other investors include 83North, C4 Ventures, Ervington Investments, Expansion Venture Capital, Hearst Ventures, Kapor Capital, Lior Prosor, Pitango, Planven, Poalim, and RiverPark.

As part of the joint venture, the German car maker will be supplying Via with the nine-seat Vito Tourer and the eight-seat V-Class passenger vans.

Via has a Multi-City Presence

Via already runs their service in New York City, Chicago, and Washington, D.C. Their licensing program allows bus services and other transport organizations to offer their own ride-sharing services.

 

Via also plans to launch their service in London, England within the year. In the recent absence of Uber in the city, Citymapper will be Via’s main competitor there as it is already offering a similar service.

At the same time, Via already has a partnership with bus operator Arriva; their app ArrivaClick is a ride sharing utility operating in Sittingbourne, England. Daimler Benz, the parent of Mercedes, also acquired MyTaxi, which is Europe’s largest taxi app.

With Daimler’s continuing investments in transport apps, it stands to reason that they are trying to find a niche for their vehicles. This is a horizontal reach for the German car giant. With their vans in use by Via in the United States, this can be a bold marketing opportunity as well. With Via’s “on-demand shuttle operating system,” there would be efficiencies of scale for operating in these major cities.

Part of the $50 million investment includes Daimler bringing the app to Europe. The car maker will also be configuring their vans to better fit Via’s purposes. Ride sharing is a bold idea that is gaining traction worldwide. As the industry matures, various niche markets are arising. Mercedes Benz is taking bold action to carve out a place in the growing sector.

Google Snaps Up Senosis Health

Manufacturers of smartphones and wearables are in a race to put health monitoring and medical diagnostics tools into their devices. This natural progression goes beyond monitoring blood pressure, heart rate, speed, and other health indicators. When successful, ideas such as these create bold impacts not just for the tech industry but for the people who use these types of devices.

Founded by Shwetak Patel, Senosis Health’s apps gives health professionals access to health information very quickly even if they are not in the clinic.

Recently, Google got ahead of the game when they acquired Senosis Health, a Seattle-based startup that developed three apps which turn smartphones into medical monitoring systems. These bold ideas left the completion behind, such as Apple’s idea of monitoring blood glucose levels with a wearable has not yet come to fruition. It is not yet clear whether their device will be part of the Apple Watch or something else entirely.

Founded by Shwetak Patel, Senosis Health’s apps give health professionals access to health information very quickly even if they are not in the clinic. The company’s developments are most useful for underdeveloped and developing countries, as well as rural areas that lack access to advanced equipment for health monitoring.

Medical monitoring devices typically are relatively large devices used in hospitals and clinics for specific purposes. Senosis Health put the functionality of these devices in standard smartphones without any need of additional equipment, using a smartphone’s built-in camera, flash, accelerometer and microphone. The apps monitor hemoglobin count, overall lung health, and detect early jaundice in newborn babies.

Senosis Health developed SpiroSmart, HemaApp, and BiliCam. SpiroSmart measures lung function, and works together with SpiroCall (a health sensing tool created by University of Washington researchers) to optionally call a toll free number. The phone call allows the user to check for lung function even if the phone is not a smartphone. The microphone is used as a spirometer, and can be used to screen for asthma and other pulmonary disease, and even cystic fibrosis.

Senosis’s second app is HemaApp, which uses the flash and camera to check hemoglobin count. Fluctuating hemoglobin count can be an indicator of malnutrition, anemia, and pulmonary illness.

The third app, BiliCam, screens for jaundice in newborn babies. It takes a picture with the camera and then analyzes the image by examining the skin’s absorption of different light wavelengths. The results provide the bilirubin level in the blood.

Digital Medical Technology

These apps are robust innovations of existing devices compatible with today’s cellphones. In addition to monitoring individuals, these apps can monitor whole communities. In some cases they eliminate the need to draw blood from patients. In addition, the apps provide results almost immediately without the dangers of sample contamination or patient infection.

 

Senosis Health is not Patel’s first startup. He is the founder of Zensi, a company that created energy monitoring solutions, which was later acquired by Belkin in 2010. He then founded WallyHome which created a sensor technology able to detect changes in moisture, temperature, and humidity in rooms. The company was sold to Sears in 2015.

Patel is a visiting researcher at Microsoft and a professor at the University of Washington. Besides being a serial entrepreneur, Patel was also a MacArthur Genius Grant recipient in 2011.

Google’s parent company Alphabet has its own life sciences division, Verily, which has invested in other health-industry related startups, including; Freenome and Lift Labs. Google also launched DeepMind Health which was tasked to create apps for doctors to diagnose and identify diseases. It is not yet clear what role Senosis Health will play within the Google organization.

But with such a variety of apps that provide so much capability, there is no doubt bold action to be taken. Google has the deep pockets and the reach to put these life saving devices into the hands of people all over the world.

How can we help?

Bold Business
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.